These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4338441)

  • 21. [Neurochemical investigation on spinocerebellar degeneration--metabolites of biogenic amines in the cerebrospinal fluids].
    Arai M; Kurosawa T; Hiyamuta E; Okada M; Kanai A
    Rinsho Shinkeigaku; 1983 Jun; 23(6):501-8. PubMed ID: 6652996
    [No Abstract]   [Full Text] [Related]  

  • 22. [Monoamine metabolites and cyclic nucleotides in the cerebrospinal fluid of patients with bismuth or mercury poisoning].
    Cramer H; Renaud B; Billiard M; Mouret J; Hammers R
    Arch Psychiatr Nervenkr (1970); 1978 Dec; 226(3):173-81. PubMed ID: 216333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Hydroxyindoleacetic acid in cerebrospinal fluid.
    Molnár G; Fodor A; Karczag I; Szilágyi A; Ujvárosi I
    Acta Med Acad Sci Hung; 1973; 30(3):211-7. PubMed ID: 4785998
    [No Abstract]   [Full Text] [Related]  

  • 24. [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data].
    Carrieri P; Mandarini A; Campanella G
    Acta Neurol (Napoli); 1975; 30(5):449-54. PubMed ID: 132845
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of probenecid on transport and metabolism of cyclic AMP by isolated rabbit renal tubules.
    Podevin RA; Boumendil-Podevin EF; Bujoli-Roche J; Priol C
    Biochim Biophys Acta; 1980 Apr; 629(1):135-42. PubMed ID: 6245714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF cyclic nucleotides and somatostatin in Parkinson's disease.
    Volicer L; Beal MF; Direnfeld LK; Marquis JK; Albert ML
    Neurology; 1986 Jan; 36(1):89-92. PubMed ID: 2867490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF AMP in primary affective disorder: effects of probenecid and tryptophan.
    Goodnick PJ; Perel JM; Dunner DL; Fieve RR
    Biol Psychiatry; 1980 Feb; 15(1):173-6. PubMed ID: 6244008
    [No Abstract]   [Full Text] [Related]  

  • 28. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
    Vanderheyden JE; Noel G; Mendlewicz J
    Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diazepam binding inhibitor in brain and in cerebrospinal fluid of human.
    Ferrero P; Penna P; Vischia F; Tarenzi L; Bergamasco B; Bergamini L
    Ann Ist Super Sanita; 1988; 24(3):443-59. PubMed ID: 3190067
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of metabolites, papaverine, and probenecid on cyclic AMP efflux from isolated rat Islets of Langerhans.
    Campbell IL; Taylor KW
    Biochim Biophys Acta; 1981 Sep; 676(3):357-64. PubMed ID: 6269653
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous probenecid loading. Effects on plasma and cerebrospinal fluid probenecid levels and on monoamine metabolites in cerebrospinal fluid.
    Kartzinel R; Ebert MH; Chase TN
    Neurology; 1976 Oct; 26(10):992-6. PubMed ID: 134293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroleptics reduce spinal fluid cyclic AMP in schizophrenic patient.
    Biederman J; Rimon R; Ebstein R; Zohar J; Belmaker R
    Neuropsychobiology; 1976; 2(5-6):324-7. PubMed ID: 197445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of probenecid on metabolic clearance rate and production rate of plasma cyclic adenosine 3', 5'-monophosphate (cAMP) in rats].
    Yang SL; Huang SL; Wen YY; Wang SZ
    Yao Xue Xue Bao; 1983 Apr; 18(4):307-9. PubMed ID: 6312739
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclic AMP levels in cerebrospinal fluid in manic-melancholic patients.
    Geisler A; Bech P; Johannesen M; Rafaelsen OJ
    Neuropsychobiology; 1976; 2(4):211-20. PubMed ID: 189250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid concentration of cyclic adenosine-3',5'-monophosphate and pneumoencephalography.
    Myllylä VV; Vapaatalo H; Hokkanen E; Heikkinen ER
    Eur Neurol; 1974; 12(1):28-32. PubMed ID: 4369838
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurochemical analysis of cerebrospinal fluid.
    Wood JH
    Neurology; 1980 Jun; 30(6):645-51. PubMed ID: 6155644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Levels of cyclic adenosine-3',5'-monophosphate (cyclic AMP) and cyclic guanosine-3',5'-monophosphate (cyclic GMP) in human lumbar and ventricular cerebrospinal fluid. Changes in coma].
    Livrea P; di Reda N; de Blasi A; Pierangeli E; Fiore T; Bertolino A
    Acta Neurol Quad (Napoli); 1978; 37():9-17. PubMed ID: 229691
    [No Abstract]   [Full Text] [Related]  

  • 38. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
    Extein I; Van Woert M; Roth RH; Bowers MB
    Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic nucleotide metabolism in neurological disease.
    Brooks BR; Wood J; Sode J; Engel WK
    Trans Am Neurol Assoc; 1976; 101():221-2. PubMed ID: 195381
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of nephrectomy and probenecid on in vivo clearance of adenosine-3',5'-monophosphate from rat plasma.
    Coulson R; Bowman RH; Roch-Ramel F
    Life Sci; 1974 Sep; 15(5):877-86. PubMed ID: 4378087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.